Predicta Med

Connecting the Dots of Undiagnosed Diseases

Health Tech & Life Sciences
Active
Seed Ramat Gan Founded 2020
Total raised
$5.5M
Stage
Seed
Founded
2020
Headcount
20
HQ
Ramat Gan
Sector
Health Tech & Life Sciences

About

Predicta Med is a platform that enables early detection and intervention selection of autoimmune diseases. Its platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient's care. A process which typically takes more than four years and at least four different doctors can be shortened significantly using the platform.

Predicta Med’s deep learning engine aggregates EMR and claims data, and enriches and analyzes this data using state-of-the-art learning techniques. The platform discovers patients at risk of having an autoimmune disease and provides actionable insights to enable optimal intervention.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceDeep LearningNatural Language Processing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

osteoarthritismultiple-sclerosisrecommendationsdiagnosticsceliac-diseaseemralgorithmsautoimmune-diseasesdecision-supportdigital-healthcaremedical-dataartificial-intelligenceearly-detection